Home AgeX Therapeutics

AgeX Therapeutics

Agex Therapeutics CEO Dr. Michael D. West to Present at Three Conferences in March 2018 

March 01, 2018 08:00 AM Eastern Standard Time ALAMEDA, Calif.–(BUSINESS WIRE)–AgeX Therapeutics, Inc., a subsidiary of BioTime, Inc. (NYSE American: BTX) today announced that the...

BioTime Subsidiary AgeX Therapeutics Appoints Aubrey de Grey, Ph.D. as VP of New Technology Discovery

  World-Renowned Aging Researcher and Biomedical Gerontologist to Lead AgeX’s Research AgeX Therapeutics (“AgeX”), a subsidiary of BioTime, Inc. (NYSE MKT:BTX) with a focus on developing...

Must Read

LifeSPARC Advanced Circulatory Support System

“LifeSPARC is the new generation pump and controller for the venerable Tandem system – a small but powerful heart pump with a magnetic bearing, a low-profile controller and a highly simplified user interface. I believe many more patients will have access to this higher level of support for the first time,” said Dr. David Baran, System Director for Advanced Heart Failure Transplant and Mechanical Circulatory Support at Sentara Heart Hospital in Norfolk, Va.

Endotronix Enrolls First Patient in SIRONA II CE Mark Trial

“SIRONA II builds on the success of our First-in-Human trial and expands our experience with the Cordella Sensor as we progress towards receiving our CE Mark,” stated Katrin Leadley, MD, Chief Medical Officer of Endotronix.

Joe Montana Professional Football Hall of Famer Joins Stimwave Technologies As Official Spokesperson

“After years of dealing with the residual effects of my professional football career, I am excited to have found this battery-free, minimally-invasive alternative to opioids that relieves chronic pain and I’m eager to help other chronic pain sufferers receive this life-changing micro-implant,” said Montana.